Cancer Drug Current Events | Cancer Drug News | 11
|
| Page
11 of
140 |
2789 Results |
|
|
|
Sort By:
Page Views | Date |
Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US
A patient's expectations about the side effects of chemotherapy usually focus on nausea, hair loss, fatigue and other side effects. Worries about severe allergic reactions to their therapy is usually not a concern. view more (2007-08-21)
Gene mutation improves leukemia drug's effect
Gene mutations that make cells cancerous can sometimes also make them more sensitive to chemotherapy. A new study led by cancer researchers at Ohio State University shows that a mutation present in some cases of acute leukemia makes the disease more susceptible to high doses of a particular anticancer drug. view more (2008-06-18)
Targeting Tumor Behavior May Lead To New Liver Cancer Drugs
Ohio State University cancer researchers have used computational and genomic methods to identify possible anti-cancer agents that may block a particular kind of tumor behavior. view more (2009-06-19)
Study finds cardiac toxicity rates high with herceptin use
The first study to look at "real world" use of Herceptin in advanced breast cancer patients found a higher incidence of cardiac toxicity - 28 percent of patients treated - than clinical trials of the drug have reported to date, but also concluded that the majority of this heart damage could be reversed with treatment. view more (2006-08-15)
Combining math and medicine to treat leukemia
Researchers have produced a mathematical model that may lead to the development of an optimally-timed vaccine for chronic myelogenous leukemia (CML). view more (2008-06-20)
Combination therapy shows promising results in patients with advanced lung cancer
An early phase study pairing an experimental targeted therapy with a common anti-inflammatory produced promising results in patients with advanced lung cancer, researchers at UCLA's Jonsson Cancer Center reported. view more (2006-06-01)
Bevacizumab found to improve survival for patients with advanced breast cancer
Inhibiting the growth of blood vessels that supply tumors slows the progression of metastatic breast cancer according to results of a large clinical trial of Avastin, an anti-angiogenic therapy. view more (2007-12-27)
How chemotherapy drugs block blood vessel growth, slow cancer spread
Researchers at the Johns Hopkins University School of Medicine have discovered how a whole class of commonly used chemotherapy drugs can block cancer growth. view more (2009-01-23)
Scientific evidence of the significant anti-cancer effect of milk thistle
Recently, scientists demonstrated the anti-cancer effects of silibinin, a major biologically active compound of milk thistle. Being widely used as a folk remedy for liver diseases, milk thistle is safe and well-tolerated, and it protects the liver from drug or alcohol-related injury. view more (2007-11-15)
First compound that specifically kills cancer stem cells found
The cancer stem cells that drive tumor growth and resist chemotherapies and radiation treatments that kill other cancer cells aren't invincible after all. view more (2009-08-14)
Drug that interrupts a key stage of cell division shows promise for advanced solid tumors
One of the first studies to investigate the effects of a new anti-cancer drug in patients with advanced or metastatic solid tumours has shown that it is capable of halting progression of the disease, and the study has provided the first proof of the drug's mechanism of action. view more (2006-11-08)
Early exposure to synthetic estrogen puts 'DES Daughters' at higher risk for breast cancer
So-called "DES daughters," born to mothers who used the anti-miscarriage drug diethylstilbestrol during pregnancy, are at a substantially greater risk of developing breast cancer compared to women who were not exposed to the drug in utero. view more (2006-08-07)
A chemotherapy drug packs a one-two punch
Cancer can be wily, and those who treat the disease have amassed a wide array of weapons with which to fight it and kill tumors. view more (2007-02-21)
New European Drugs Research Project
The University of Kent at Canterbury (UKC) is launching a major European drugs research project at the Drugs and Society Conference at Ashford International Hotel, Kent on 24th October. The £500,000 EU-funded project will investigate the use of court-ordered drug treatment in the UK, the Netherlands, Germany, Italy, Austria and Switzerland.... view more... (2002-10-11)
Study shows blood markers can help choose best dose for antiangiogenic drugs
Scientists at Sunnybrook have new information that may help to improve the use of anti-cancer drugs designed to block the growth of new blood vessels in tumors, a process called angiogenesis that is critical to tumor growth. view more (2007-10-26)
U of Minnesota study finds thalidomide shows promise for treatment of recurrent ovarian cancer
Thalidomide, a drug blamed in the 1950s for causing birth defects, is now showing promise as a safe and effective treatment for women with recurrent ovarian cancer, according to a study led by a University of Minnesota Cancer Center researcher. view more (2008-02-28)
Transmission of drug-resistant HIV-1
Drug-resistant forms of HIV can be spread between individuals who have not received anti-retroviral treatment. view more (2009-03-30)
Study finds cisplatin less effective than standard treatment for patients with anal cancer
When administered before chemoradiation, the common anti-cancer drug cisplatin neither improved disease-free survival nor reduced the number of colostomies needed when compared to the standard treatment for patients with anal canal cancer, according to a study published in the April 23 issue of the Journal of the American Medical Association. view more (2008-04-23)
Cancer Research director receives SCI accolade
9 July 2003, London, UK: Professor Sir David Lane, Director of the Cancer Research UK Transformation Research Group, will be awarded the Society of Chemical Industry (SCI) 2003 Society Medal today. The medal will be presented in recognition of his exceptional services to applied chemistry and the improvement of society at the 122nd Annual Meeting... view more... (2003-07-08)
Tamoxifen chemoprevention tied to early detection of breast cancer
The drug tamoxifen does not prevent or treat estrogen receptor (ER) negative breast cancer, but it can make the disease easier to find, researchers report in the Oct. 1 Journal of the National Cancer Institute. view more (2008-10-08)
|
|
| Page
11 of
140 |
2789 Results |
|
|
|
Sort By:
Page Views | Date |
|
